Risk communication during COVID-19

dc.creatorAbrams, Elissa M.
dc.creatorGreenhawt, Matthew
dc.date.accessioned2020-05-07T17:05:24Z
dc.date.available2020-05-07T17:05:24Z
dc.date.issued2020-04
dc.description.abstractIndisponível.pt_BR
dc.identifier.citationABRAMS, E. M; GREENHAWT, M. Risk communication during COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, [S.l.], Apr. 2020. No prelo.pt_BR
dc.identifier.urihttps://repositorio.ufla.br/handle/1/40677
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S2213219820303639pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsopenAccesspt_BR
dc.sourceThe Journal of Allergy and Clinical Immunology: In Practicept_BR
dc.subjectCOVID-19pt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)pt_BR
dc.subjectRisk communicationpt_BR
dc.subjectHealth policypt_BR
dc.subjectPandemicpt_BR
dc.titleRisk communication during COVID-19pt_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
953 B
Formato:
Item-specific license agreed upon to submission
Descrição: